Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1994-08-10
1999-07-20
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
4241841, 424520, 424559, 424812, 424 932, 424450, 514 44, A61K 3548, A61K 4800
Patent
active
059253622
ABSTRACT:
Vaccines capable of eliciting an immune antitumor response for prostate tumors are disclosed. The active ingredient in such vaccines is selected from the group consisting of human PSA and expression system capable of generating in situ human PSA.
REFERENCES:
patent: Re33405 (1990-10-01), Chu et al.
patent: 3960827 (1976-06-01), Bjorklund
patent: 4372945 (1983-02-01), Likhite
patent: 4446122 (1984-05-01), Chu et al.
patent: 4468457 (1984-08-01), Goldenberg et al.
patent: 4689222 (1987-08-01), McMichael
patent: 4877611 (1989-10-01), Cantrell
patent: 5053224 (1991-10-01), Koprowski et al.
Murphy et al. The Prostate 29:371-380 (1996).
Salgaller et al. Proc Am Assoc Cancer Res 38:616 (1997).
Tsang et al. JNCI 87:982-990 (1995).
Wright et al. Int. J. Cancer 47:717-725 (1991) Abstract Only.
Beckett et al. Cancer Res. Search 51:1326-1333 (1991) Abstract Only.
Hodge et al. Int. J. Cancer 63:231-237 (1995).
Spitler et al. Cancer Biotherapy 10:1-3 (1995).
Ezzell J NIH Research 7:46-49 (1995).
Vieweg et al. Cancer Research 54:1760-1765 (1994).
Linehan et al. JNCI 87:331-332 (1995).
Boring, CC, et al, Cancer Statistic, 1993:CA Cancer J Clin (1993) 43:7-26.
Hoover, Jr. HC and Hanna, Jr. MG, Biological Therapy of Cancer (1991) Devita, Jr., DT, et al., Biologic Therapy of Cancer; eds. J.B. Lippincott Co., pp. 670-701.
Deguchi et al., Effect of Methotrexate-Monoclonal Anti-Prostatic Acid Phosphatase Antibody Conjugate on Human Prostate Tumor, Cancer Research 45:3751-3755.
Alving, C.R., Liposomes as Carriers of Anitgens and Adjuvants, J. Imunol. Methods 140:1-13 (1990).
Faseb, J., Generation and Characterization of Monoclonal Anti-Idiotypic Antibodies for Dunning Rat Prostate Tumor, Abstract No. 2301; A692 entire abstract (1988).
Maida, III Anthony E.
Spitler Lynn E.
Chan Christina Y.
Gambel Phillip
Jenner Technologies
LandOfFree
Method to elicit an antitumor response with human prostate-speci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to elicit an antitumor response with human prostate-speci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to elicit an antitumor response with human prostate-speci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320112